Annual Meeting & Reports
Notice Regarding Financial Reporting Standard (FRS) 102 Adoption
Medtronic plc Parent Entity Irish Statutory Financial Statements
Notice to Shareholders of Reduced Disclosure Requirements
Changes in Irish accounting regulations require the Company to adopt a new accounting framework for its parent entity Irish statutory financial statements for the financial year ended April 29, 2016. We consider it to be in the best interests of the Company to adopt FRS 102 (The Financial Reporting Standard Applicable in the U.K. and Republic of Ireland) for the financial year ended April 29, 2016. The Company intends to utilize the disclosure exemptions available. No disclosures in the consolidated U.S. GAAP financial statements would be omitted on adoption of FRS 102 by the parent entity for its Irish statutory financial statements. A shareholder or shareholders having an aggregate holding of 5% or more of the total outstanding ordinary shares in the Company may serve objections in writing to the use of the disclosure exemptions to the Company Secretary at Medtronic plc, 20 On Hatch, Lower Hatch Street, Dublin 2, Ireland before midday, Irish Time on September 1, 2016.
2016 Annual Meeting
The board of directors of Medtronic plc (NYSE: MDT) announced that the company's annual meeting of shareholders will be held on:
Friday, December 9, 2016
8:00 a.m. Irish Standard Time
Shareholders of record at the close of business on October 11, 2016, will be eligible to vote at the meeting.
Annual Reports & Proxy Statements
Fiscal Year 2016 – Medtronic plc Annual Filings
Annual Report Filing SEC Form 10K – Fiscal Year 2016 (pdf)
Medtronic plc Fiscal Year 2016 Proxy Statement - SEC form 14A
Irish Statutory Report - Fiscal 2016
Medtronic plc 2016 CEO Letter to Shareholders
Medtronic plc 2016 Integrated SRI Report
Fiscal Year 2015 – Medtronic plc Annual Filings
Annual Report Filing SEC Form 10K - Fiscal Year 2015 (pdf)
Medtronic plc Fiscal Year 2015 Proxy Materials
Irish Statutory Report - Fiscal 2015
Medtronic plc 2015 CEO Letter to Shareholders
Medtronic plc 2015 Integrated SRI Report
Fiscal Year 2014 – Medtronic, Inc. Annual Filings
Annual Report Filing SEC Form 10K - Fiscal Year 2014 (pdf)
Medtronic 2014 Proxy Statement - SEC form 14A
Medtronic SEC Filing Form S-4A No 5 - Filed 11-20-2014
Medtronic Inc 2014 CEO Letter to Shareholders
Medtronic Inc 2014 Integrated SRI Report
2013 Annual Report
2013 Annual Report (pdf)
2012 Annual Report
2012 Annual Report (pdf)
2011 Annual Report
2011 Annual Report (pdf)
Requests can also be made through our fulfillment agent, Broadridge, by telephone at 1-800-579-1639 or by internet at www.proxyvote.com.
Requests for original copies of Medtronic's Annual Report and Proxy Statement can be made by contacting Medtronic Investor Relations at email@example.com or by telephone at 763-505-2692.
You may visit Medtronic's home page at www.medtronic.com.
*Note: Adobe Acrobat® Reader is needed to view and print PDF files. Get Adobe Acrobat® Reader. Follow the instructions provided